Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Kitcheetahon Mar 30, 2017 12:13pm

134 Views

Post# 26052695

RE:RE:RE:RE:RE:RE:You can hear a pin drop..

Bunge wrote:

goldn1 wrote:
No worries, we are just halted... $7.00 buyout coming...

$7 would be disappointing if this works and expands to all those other cancer applications.

i would be dissapointed with $7.00 myself. when i search for halts though i dont see TLT on the TSXV list?

https://www.iiroc.ca/news/Pages/Halts-Resumptions.aspx

Bullboard Posts

Changing Europe’s dependency on HREE from China